Research body opens market engagement on long-read sequencing system
A research institute is exploring the market for an integrated long-read DNA/RNA sequencing system with local data processing to support advanced genomic work.
A research institute is exploring the market for an integrated long-read DNA/RNA sequencing system with local data processing to support advanced genomic work.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.
A national research network’s technology institute is preparing the ground for a major upgrade to its genomics infrastructure, signalling plans to buy an integrated DNA/RNA sequencing system with high-performance long-read capability, local data processing and dedicated software for advanced analyses.
On 30th April 2026, Sieć Badawcza Łukasiewicz - PORT Polski Ośrodek Rozwoju Technologii published a prior information notice for DNA/RNA Sequencing System Delivery. The notice trails the planned delivery, installation and commissioning of an “integrated nucleic acid sequencing system” designed for advanced genomic work.
The institute is specifically looking for a system that can deliver high-performance long-read sequencing. Alongside the instrument itself, the notice highlights local data processing and dedicated software as core components. That points to a desire for a complete platform that can take samples from raw sequence output through to analysis on site, rather than relying solely on external computing infrastructure.
While the notice does not set out detailed technical specifications, the emphasis on long-read sequencing and integration suggests the institute wants to run complex genomic analyses within a controlled, in-house environment. The inclusion of commissioning in scope also indicates that the supplier will be expected to take responsibility for ensuring the system is fully operational within the laboratory.
The focus on an integrated solution mirrors a broader shift in recent procurements, where buyers increasingly seek end-to-end sequencing infrastructures rather than standalone boxes.
In November 2025, a medical university issued a contract for a Server Bioinformatics Platform Delivery, covering delivery, installation, commissioning, on-site training and warranty maintenance for a platform intended for “ultra-fast secondary analysis” of next-generation sequencing data. Here, the computing layer is treated as a strategic asset in its own right, procured and supported alongside wet-lab capacity.
A similar pattern appears in a December 2025 contract from Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej, which sought a High-Throughput Sequencing Kit Delivery. That tender combined a high-throughput sequencing kit with a control station and software, plus assembly, installation and staff training. It underlines that buyers now tend to specify software, control hardware and knowledge transfer as part of a single package.
On the data-processing side, a April 2026 notice from Univerzita Karlova for a Next Generation Sequencing Platform explicitly couples DNA sequencing and fragmentation equipment with servers for data processing and analysis. That project is aimed at advancing research and treatment of rare diseases, and again ties the analytical computing environment directly into the hardware purchase.
These examples suggest that suppliers responding to Łukasiewicz - PORT’s market engagement will need to think beyond the sequencer itself. Long-read performance, robust local data processing, and mature software environments are all central to how public-sector buyers now frame their sequencing needs.
The Łukasiewicz - PORT notice makes long-read sequencing a headline requirement. That interest is widely shared. Across recent tenders, long-read and even ultra-long DNA analysis capabilities are becoming a defining feature of new platforms.
In February 2026, the B. Dobrzański Institute of Agrophysics launched a contract for a Nucleic Acid Sequencing System Delivery using long-read technology for the analysis of plant holobionts. The notice specifies a warranty period and technical parameters, showing how long-read capability is being applied to complex plant–microbe systems as well as to human health.
At the clinical research end of the spectrum, the Institute of Experimental Biology M. Nenckiego PAN set out in March 2026 to buy a Nucleic Acid Analysis Device that combines high-throughput long-read sequencing with the ability to read epigenetic information, plus training for employees. This underlines that many buyers now see long-read platforms as tools for richer genomic and epigenomic characterisation in a single system.
Ultra-long capability is also emerging. In April 2026, Masarykova univerzita published a contract notice for an Ultra-Long DNA Analysis System, seeking a device to analyse ultra-long DNA molecules and determine structural and numerical variants of the genome at a preclinical centre. Long-read capability here is tied directly to the ability to resolve complex genomic changes.
The Latvian Biomedical Research and Study Centre took a related route in February 2026, launching a tender for Nanopore Sequencing Equipment Acquisition. That procurement covers long-read, nanopore-based high-throughput parallel sequencing equipment, along with reagents, materials and software, and allows for both acquisition and rental models.
Seen against this backdrop, Łukasiewicz - PORT’s interest in a high-performance long-read system aligns with a clear direction of travel: public laboratories are equipping themselves for more demanding genomic questions, and they expect instruments, chemistry, data handling and software to move together.
The Łukasiewicz - PORT notice is framed around “advanced genomic analyses” without tying the system to a single application area. That open framing reflects how similar platforms are now used across clinical diagnostics, fundamental research and agriculture.
On the clinical side, a March 2026 notice from Fakultní nemocnice Motol a Homolka seeks Sequencing Equipment for an Oncology Center, including devices for high-precision whole-genome and whole-transcriptome sequencing for research and diagnostic use. Earlier, in November 2025, A.O. Sant'Andrea issued a contract notice for the Supply of Nucleic Acid Sequencing Equipment and associated reagents and consumables for molecular biology investigations at a healthcare facility.
Rare disease research is a separate but closely related driver. The April 2026 Univerzita Karlova Next Generation Sequencing Platform explicitly links the new DNA sequencing and data-processing hardware to advancing research and treatment of rare conditions. In Romania, a February 2026 notice from Universitatea de Medicina si Farmacie "Carol Davila" covers Genomic Research Equipment Supply, combining high-throughput and portable sequencing systems for several medical research institutions.
Beyond medicine, long-read systems are being deployed in agri-food and environmental research. The B. Dobrzański Institute of Agrophysics’ February 2026 long-read system for plant holobionts places microbiome-aware plant science within reach of the same technology stack. In April 2026, Agraren universitet - Plovdiv followed with a tender for a Long-Chain Sequencing System Installation to support an Agro-Food Systems and Bioeconomy competence centre.
Regulatory and public health agencies are also upgrading. In March 2026, AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH issued a contract notice for a Next Generation Sequencing System, covering delivery, assembly, installation and commissioning of a new advanced platform.
Łukasiewicz - PORT’s proposed system, aimed broadly at “advanced genomic analyses”, would sit comfortably within this landscape, able in principle to support research collaborations that touch health, industrial biotechnology and agri-food questions.
Because Łukasiewicz - PORT’s notice is a prior information notice, it is a signal to the market rather than a full contract specification. It gives suppliers an early view of the planned scope – an integrated long-read sequencing system with local data processing and dedicated software – and indicates that a more detailed procurement may follow.
Other recent notices show how varied that next stage could be. Some buyers have opted for rental-based models. In December 2025, Universitätsklinikum Halle (Saale) AöR advertised an Integrated Sequencing Device for next-generation sequencing on a rental basis with consumables and personnel training, and an option to purchase later. In March 2026, the National Institute of Oncology launched a Sequencing Device Rental to support molecular diagnostics, explicitly tying performance and maintenance to the rental period.
Others, such as Instytut "Pomnik-Centrum Zdrowia Dziecka" in January 2026, have used targeted grants to modernise equipment through a tender for the Supply of Sequencer and Electrophoresis System. And some organisations are, like Łukasiewicz - PORT, using prior information notices to explore what the market can offer before finalising their route to market, as seen in the November 2025 Sequencer Procurement Exploration by Medizinische Universität Innsbruck.
For potential suppliers, the Łukasiewicz - PORT notice highlights several themes likely to shape any future tender: the need to demonstrate proven long-read performance; the ability to supply and support local data processing infrastructure as part of the offer; and the expectation that dedicated software will form an integral, supported element of the solution.
What happens next will depend on how the institute refines its requirements following this market engagement. If it follows the pattern of other laboratories and health bodies, the eventual competition could place as much weight on data handling, training and long-term support as on the core sequencing specifications themselves.
For now, the notice confirms that demand for integrated long-read DNA/RNA sequencing systems continues to build across the public sector, with Łukasiewicz - PORT positioning itself among the laboratories preparing for the next wave of genomic analysis.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.